Found: 208
Select item for more details and to access through your institution.
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 13, p. 1, doi. 10.1161/JAHA.123.033544
- By:
- Publication type:
- Article
Cardiovascular Burden of the V142I Transthyretin Variant.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 21, p. 1824, doi. 10.1001/jama.2024.4467
- By:
- Publication type:
- Article
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
- By:
- Publication type:
- Article
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1334, doi. 10.1002/ejhf.3266
- By:
- Publication type:
- Article
Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Effects of high‐dose versus standard‐dose quadrivalent influenza vaccine among patients with diabetes: A post‐hoc analysis of the DANFLU‐1 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1821, doi. 10.1111/dom.15498
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1125, doi. 10.1002/ejhf.3223
- By:
- Publication type:
- Article
Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination: A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation Trial.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 4, p. 476, doi. 10.7326/M23-2638
- By:
- Publication type:
- Article
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON‐HF study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 871, doi. 10.1002/ejhf.3167
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 912, doi. 10.1002/ejhf.3184
- By:
- Publication type:
- Article
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 5, p. 1, doi. 10.1161/JAHA.123.032279
- By:
- Publication type:
- Article
Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44680-3
- By:
- Publication type:
- Article
Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 130, doi. 10.1002/ejhf.3079
- By:
- Publication type:
- Article
Electronically Delivered Nudges to Increase Influenza Vaccination Uptake in Older Adults With Diabetes: A Secondary Analysis of the NUDGE-FLU Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2347630, doi. 10.1001/jamanetworkopen.2023.47630
- By:
- Publication type:
- Article
Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2177, doi. 10.1002/ejhf.3043
- By:
- Publication type:
- Article
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
- By:
- Publication type:
- Article
Circulating neutrophil‐related proteins associate with incident heart failure and cardiac dysfunction: The ARIC study.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 1923, doi. 10.1002/ejhf.3008
- By:
- Publication type:
- Article
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 9, p. e2331284, doi. 10.1001/jamanetworkopen.2023.31284
- By:
- Publication type:
- Article
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 17, p. 1, doi. 10.1161/JAHA.122.028942
- By:
- Publication type:
- Article
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1663, doi. 10.1002/ejhf.3001
- By:
- Publication type:
- Article
Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta‐analysis.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1685, doi. 10.1002/ejhf.2945
- By:
- Publication type:
- Article
Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities Study.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 16, p. 1, doi. 10.1161/JAHA.122.029458
- By:
- Publication type:
- Article
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2930, doi. 10.1093/eurheartj/ehad283
- By:
- Publication type:
- Article
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2982, doi. 10.1093/eurheartj/ehad344
- By:
- Publication type:
- Article
Link between myocardial deformation phenotyping using longitudinal and circumferential strain and risk of incident heart failure and cardiovascular death.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 8, p. 999, doi. 10.1093/ehjci/jead075
- By:
- Publication type:
- Article
Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fraction.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 8, p. 1110, doi. 10.1093/ehjci/jead062
- By:
- Publication type:
- Article
Geographic differences in patients with acute myocardial infarction in the PARADISE‐MI trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1228, doi. 10.1002/ejhf.2851
- By:
- Publication type:
- Article
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1364, doi. 10.1002/ejhf.2912
- By:
- Publication type:
- Article
Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1396, doi. 10.1002/ejhf.2957
- By:
- Publication type:
- Article
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: A pre‐specified analysis of the NUDGE‐FLU trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1450, doi. 10.1002/ejhf.2913
- By:
- Publication type:
- Article
Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities Study.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 15, p. 1, doi. 10.1161/JAHA.122.029458
- By:
- Publication type:
- Article
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1890, doi. 10.1093/ndt/gfac342
- By:
- Publication type:
- Article
Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant‐level pooled analysis from the DAPA‐HF and DELIVER trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 981, doi. 10.1002/ejhf.2909
- By:
- Publication type:
- Article
Potential global impact of sodium–glucose cotransporter‐2 inhibitors in heart failure.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 999, doi. 10.1002/ejhf.2864
- By:
- Publication type:
- Article
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 1170, doi. 10.1002/ejhf.2915
- By:
- Publication type:
- Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2170, doi. 10.1093/eurheartj/ehad276
- By:
- Publication type:
- Article
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1125, doi. 10.1111/dom.14954
- By:
- Publication type:
- Article
Long‐term durability of antibody responses after SARS‐CoV‐2 vaccination and influencing factors.
- Published in:
- Journal of Internal Medicine, 2023, v. 293, n. 4, p. 520, doi. 10.1111/joim.13601
- By:
- Publication type:
- Article
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MI.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2023, v. 12, n. 3, p. 155, doi. 10.1093/ehjacc/zuad001
- By:
- Publication type:
- Article
Serological response to vaccination in post-acute sequelae of COVID.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08060-y
- By:
- Publication type:
- Article
Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e2255965, doi. 10.1001/jamanetworkopen.2022.55965
- By:
- Publication type:
- Article
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 2, p. 248, doi. 10.1002/ejhf.2763
- By:
- Publication type:
- Article
Association of post‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 2, p. 299, doi. 10.1002/ejhf.2716
- By:
- Publication type:
- Article
Measures of Food Inadequacy and Cardiovascular Disease Risk in Black Individuals in the US From the Jackson Heart Study.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2252055, doi. 10.1001/jamanetworkopen.2022.52055
- By:
- Publication type:
- Article
Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 54, doi. 10.1002/ejhf.2699
- By:
- Publication type:
- Article
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 87, doi. 10.1002/ejhf.2703
- By:
- Publication type:
- Article
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 5006, doi. 10.1093/eurheartj/ehac293
- By:
- Publication type:
- Article
Health‐related quality of life outcomes in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2264, doi. 10.1002/ejhf.2738
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2307, doi. 10.1002/ejhf.2722
- By:
- Publication type:
- Article
A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34245-1
- By:
- Publication type:
- Article